The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - … (NCT04193722) | Clinical Trial Compass
CompletedPhase 3
The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - UMBRELLA HONEY Trial
Netherlands189 participantsStarted 2019-08-28
Plain-language summary
The "Hyperbaric OxygeN therapy on brEast cancer patients with late radiation toxicity" (HONEY) trial aims to evaluate the effectiveness of HBOT on late radiation toxicity in breast cancer patients using the trial within cohorts (TwiCs) design.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Self reported pain grade 3-4 (on a scale of 1-4) as assessed by the late radiation toxicity questionnaire;
* Participation \>12 months in the UMBRELLA cohort;
* Previous treatment with radiotherapy for breast cancer;
* Completed surgery and (neo)adjuvant systemic therapy except adjuvant endocrine therapy, for breast cancer.
Exclusion Criteria:
* Poor responder to questionnaires (i.e. return of ≤ 2 UMBRELLA questionnaires);
* Previous HBOT;
* Contra-indications for HBOT (e.g. (severe) chronic obstructive pulmonary disease (COPD) or asthma, pacemaker, morbid obesity, epilepsy in medical history, severe heart failure);
* Current metastatic disease or recurrent breast cancer.
Additional exclusions criteria based on screening visit:
* Inability to follow schedule of all consecutive HBO treatments (e.g. due to scheduled holidays \> 2 days);
* Not meeting criteria for HBOT (e.g. due to complaints similar to late radiation toxicity, not caused by radiotherapy).
What they're measuring
1
Change in breast/chest wall pain: EORTC QLQ-BR23 questionnaire
Timeframe: Baseline and 6 months after baseline (i.e. 3 months after HBOT)